Clinical and pharmacokinetic evaluation of parenteral moxalactam in infants and children.

Thirty-four infants and children ranging in age from 2.5 to 180 months (mean, 40 months) were treated with parenteral moxalactam (150 mg/kg per day) for suspected or proved bacterial infections outside the central nervous system. Six patients infected with Haemophilus influenzae b, nine infected wit...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Keyserling, H, Feldman, W E, Moffitt, S, Manning, N, Hollins, M
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1982
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC182042/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6214210/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.21.6.898
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!